Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica

被引:7
作者
Hisada, M
Lal, RB
Masciotra, S
Rudolph, DL
Martin, MP
Carrington, M
Wilks, RJ
Manns, A
机构
[1] NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA
[2] Sci Applicat Int Corp, Frederick Canc Res & Dev Ctr, Intramural Res Support Program, Frederick, MD USA
[3] CDCP, HIV Immunol & Diagnost Branch, Div AIDS STD & TB Lab Res, Natl Ctr Infect Dis, Atlanta, GA USA
[4] Univ W Indies, Res Inst Trop Med, Epidemiol Res Unit, Kingston 7, Jamaica
关键词
D O I
10.1086/340129
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Polymorphisms of some chemokine receptor genes and their ligands are associated with susceptibility and progression of human immunodeficiency virus infection. This study assessed whether these variants are also responsible for susceptibility to infection with human T lymphotropic virus (HTLV) type I. Frequencies of CCR5-Delta32, CCR2-64I, and SDF-1-3'A genotype among 116 HTLV-I-positive and 126 HTLV-I-negative persons of African descent in Jamaica were 1.0%, 14.9%, and 5.4%, respectively. The association of HTLV-I infection with the most common variant, CCR2-64I, was examined in 532 subjects. Thirteen (5.4%) of 241 HTLV-I-negative subjects were homozygous for CCR2-64I, versus 3 (1.0%) of 291 HTLV-I-positive subjects (P = .005). Among HTLV-I carriers, provirus load and antibody titer were not significantly different in persons with CCR2-+/64I or CCR2-+/+. These findings suggest that CCR2-64I, or alleles in linkage disequilibrium with it, may affect the risk of HTLV-I infection in a recessive manner.
引用
收藏
页码:1351 / 1354
页数:4
相关论文
共 15 条
[1]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[2]   CHARACTERIZATION OF HUMAN T-LYMPHOTROPIC VIRUS TYPE I-INFECTED AND II-INFECTED T-CELL LINES - ANTIGENIC, PHENOTYPIC, AND GENOTYPIC ANALYSIS [J].
DEZZUTTI, CS ;
RUDOLPH, DL ;
ROBERTS, CR ;
LAL, RB .
VIRUS RESEARCH, 1993, 29 (01) :59-70
[3]   Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes [J].
Gonzalez, E ;
Bamshad, M ;
Sato, N ;
Mummidi, S ;
Dhanda, R ;
Catano, G ;
Cabrera, S ;
McBride, M ;
Cao, XH ;
Merrill, G ;
O'Connell, P ;
Bowden, DW ;
Freedman, BI ;
Anderson, SA ;
Walter, EA ;
Evans, JS ;
Stephan, KT ;
Clark, RA ;
Tyagi, S ;
Ahuja, SS ;
Dolan, MJ ;
Ahuja, SK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (21) :12004-12009
[4]   Human T-Cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin [J].
Jassal, SR ;
Pöhler, RG ;
Brighty, DW .
JOURNAL OF VIROLOGY, 2001, 75 (17) :8317-8328
[5]   A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation [J].
Kostrikis, LG ;
Huang, YX ;
Moore, JP ;
Wolinsky, SM ;
Zhang, LQ ;
Guo, Y ;
Deutsch, L ;
Phair, J ;
Neumann, AU ;
Ho, DD .
NATURE MEDICINE, 1998, 4 (03) :350-353
[6]  
Lal RB, 1996, J IMMUNOL, V157, P1288
[7]   Use of chemokine receptors by poxviruses [J].
Lalani, AS ;
Masters, J ;
Zeng, W ;
Barrett, J ;
Pannu, R ;
Everett, H ;
Arendt, CW ;
McFadden, G .
SCIENCE, 1999, 286 (5446) :1968-1971
[8]   Human T-lymphotropic virus type I infection [J].
Manns, A ;
Hisada, M ;
La Grenade, L .
LANCET, 1999, 353 (9168) :1951-1958
[9]   Chemokine control of HIV-1 infection [J].
Mellado, M ;
Rodríguez-Frade, JM ;
Vila-Coro, AJ ;
de Ana, AM ;
Martinez, C .
NATURE, 1999, 400 (6746) :723-724
[10]   A case-control study of risk factors for seropositivity to human T-Lymphotropic virus type I (HTLV-I) in Jamaica [J].
Murphy, EL ;
Wilks, R ;
Hanchard, B ;
Cranston, B ;
Figueroa, JP ;
Gibbs, WN ;
Murphy, JYN ;
Blattner, WA .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1996, 25 (05) :1083-1089